| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
127,314,000 | 129,079,000 | 133,125,000 | 134,598,000 | 123,675,000 |
|
Cost of Revenue
|
-75,279,000 | -72,436,000 | -66,102,000 | -65,031,000 | -63,935,000 |
|
Gross Profit
|
52,035,000 | 56,643,000 | 67,023,000 | 69,567,000 | 59,740,000 |
|
Selling, General and Administrative Expenses
|
-23,478,000 | -25,843,000 | -23,620,000 | -23,519,000 | -20,514,000 |
|
Research and Development Expenses
|
-19,758,000 | -20,433,000 | -22,133,000 | -24,192,000 | -23,315,000 |
|
Operating Income/Expenses
|
-43,236,000 | -46,276,000 | -45,753,000 | -47,711,000 | -43,829,000 |
|
Total Operating Profit/Loss
|
8,799,000 | 10,367,000 | 21,270,000 | 21,856,000 | 15,911,000 |
| Total Net Finance Income/Expense
|
5,103,000 | 5,818,000 | 5,138,000 | 4,761,000 | 3,332,000 |
| Net Investment Income
|
-739,000 | 954,000 | 385,000 | -3,204,000 | -3,394,000 |
| Irregular Income/Expenses
|
-16,190,000 | -16,190,000 | 0 | 0 | -- |
|
Other Income/Expense, Non-Operating
|
-365,000 | 5,767,000 | 1,829,000 | 1,785,000 | -5,737,000 |
|
Non-Operating Income/Expenses, Total
|
-12,191,000 | -3,651,000 | 7,352,000 | 3,342,000 | -5,799,000 |
|
Pretax Income
|
-3,392,000 | 6,716,000 | 28,622,000 | 25,198,000 | 10,112,000 |
|
Provision for Income Tax
|
-729,000 | -1,259,000 | -4,447,000 | -3,649,000 | -2,578,000 |
|
Net Income from Continuing Operations
|
-4,121,000 | 5,457,000 | 24,175,000 | 21,549,000 | 7,534,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-4,121,000 | 5,457,000 | 24,175,000 | 21,549,000 | 7,534,000 |
|
Non-Controlling/Minority Interests
|
435,000 | 132,000 | -415,000 | -1,234,000 | 25,000 |
|
Net Income after Non-Controlling/Minority Interests
|
-3,686,000 | 5,589,000 | 23,760,000 | 20,315,000 | 7,559,000 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
-926,000 | -926,000 | -588,000 | -717,000 | -591,000 |
|
Net Income Available to Common Stockholders
|
-4,612,000 | 4,663,000 | 23,172,000 | 19,598,000 | 6,968,000 |
|
Dilution to Earnings
|
-620,000 | -620,000 | -105,000 | -44,000 | 0 |
|
Diluted Net Income Available to Common Stockholders
|
-5,232,000 | 4,043,000 | 23,067,000 | 19,554,000 | 6,968,000 |
| Basic EPS
|
-1.74 | 1.71 | 8.31 | 6.98 | 2.50 |
| Diluted EPS
|
-1.96 | 1.47 | 8.24 | 6.89 | 2.48 |
|
Basic Weighted Average Shares Outstanding
|
2,718,000 | 2,726,000 | 2,790,000 | 2,807,000 | 2,782,000 |
|
Diluted Weighted Average Shares Outstanding
|
2,751,000 | 2,744,000 | 2,798,000 | 2,837,000 | 2,809,000 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-8,495,000 | 898,000 | 23,484,000 | 20,437,000 | 6,780,000 |
|
EBITDA
|
-8,495,000 | 22,249,000 | 44,005,000 | 41,894,000 | 26,864,000 |
|
Normalized EBITDA
|
7,695,000 | 22,857,000 | 33,078,000 | 35,823,000 | 29,663,000 |
12/31/2022 - 3/13/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade